Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SLC6A8 contributors: mct/pgu - updated : 13-06-2018
HGNC name solute carrier family 6 (neurotransmitter transporter, creatine), member 8
HGNC id 11055
DNA
TYPE functioning gene
STRUCTURE 8.30 kb     13 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked N status confirmed
Map see L1CAM
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
13 - 3580 70.5 635 - - 18515020
13 splicing 3550 - 625 - - 18515020
also known as SLC6A8B
13 splicing 3129 58.3 520 predominantly found in human tissues with a high energy requirement such as brain, kidney, heart, small intestines and skeletal muscle - 18515020
  • also known SLC6A8C
  • prediction of a truncated protein identical to the variant 1, comprising the five last C-terminal transmembrane domains
  • EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart   highly Homo sapiens
    Nervousbrainlimbic systemhippocampusdentate gyrushighly Homo sapiens
     brainforebraincerebral cortex highly Homo sapiens
    Visualeyelens  highly Homo sapiens
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal predominantly Homo sapiens
    Nervouscentral  predominantly
    cells
    SystemCellPubmedSpeciesStageRna symbol
    Nervousastrocyte
    Nervousneuron
    Nervouspyramidal cell
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • twelve transmembrane segments
  • HOMOLOGY
    interspecies homolog to C.elegans T03F7.1
    homolog to murine Slc6a8
    Homologene
    FAMILY
  • sodium neurotransmitter symporter family
  • SLC6A8 subfamily
  • CATEGORY transport carrier
    SUBCELLULAR LOCALIZATION     plasma membrane
    text presence of a functional SLC6A8 in the axon terminal membrane that may serve to recapture the creatine released during the synapsis
    basic FUNCTION
  • Na+ (and Cl-) dependent plasma membrane transporter required for the uptake of creatine
  • playing an essential role in the storage and transmission of phosphate-bound energy
  • in most brain regions, may be transporting guanidinoacetate from GATM/GAMT-expressing cells to allow creatine synthesis
  • . is an important metabolic regulator controlling antitumor T cell immunity
    CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with SGK1, SGK3 (increase SLC6A8 activity by increasing the maximal transport rate of the carrier)
  • Klotho protein up-regulates the activity of creatine transporter SLC6A8 by stabilizing the carrier protein in the cell membrane, an effect requiring beta-glucuronidase activity of KL protein
  • both, STK39 and OSR1, are negative regulators of the creatine transporter SLC6A8
  • JAK3 is a powerful negative regulator of SLC6A8
  • cell & other
    REGULATION
    activated by FRAP1
    ASSOCIATED DISORDERS
    corresponding disease(s) CRTRD
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --low  
    in astrocytes around the blood-brain barrier limits the brain capacity to import creatine from the periphery, and suggests that the CNS has to rely mainly on endogenous creatine synthesis through GATM/GAMT
    constitutional     --low  
    depletion of intracellular creatine by ablation of the creatine transporter SLC6A8 altered macrophage-mediated immune responses
    constitutional     --low  
    in dopaminergic neurons causes hyperactivity while sparing motor function
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    potential of creatine supplementation to improve T cell-based cancer immunotherapies
    cancerlung 
    expected to become a molecular target for NSCLC treatment
    ANIMAL & CELL MODELS